pre-processing capabilities provide operators with comprehensive, automated pre-conditioning of content including support for leading CAS/DRM, file-based QA, and transcoding vendors to ensure your content is timely, accurate, and secure for markets in multiple encodings and various meta-data formats.
The Lynguent team has outstanding expertise that enables it to deliver technology to minimize the bottlenecks in today's AMS development processes.
Customers use Lynguent tools and services to create, maintain, reuse, debug, and validate AMS models and related technology to accelerate time-to-market for a wide range of state-of-the-art ICs and electronic systems.
In addition, AMS
has regional sales, marketing and administration support with an office is located in Folsom, California.
Bank, we can now offer AMS members a credit card solution that incorporates exclusive savings opportunities.
The AMS is a non-profit veteran's organization representing the professional and personal interests of active duty and retired men and women of America's Uniformed Services, National Guard and Reserve.
For the year 2006, AMS is reiterating its existing guidance for revenue from its current business to be in the range of $304 to $314 million.
AMS remains confident in the organic growth prospects of its core products as driven by a robust product pipeline.
Statements about AMS' market opportunities, future Laserscope products, sales and financial results of Laserscope products and the combined business are also forward-looking statements subject to risks and uncertainties such as the timing and success of new product introduction including but not limited to the GreenLight(TM) HPS system; successful integration of Laserscope into our business; physician acceptance, endorsement, and use of AMS and Laserscope products; regulatory matters; competitor activities; changes in and adoption of reimbursement rates; potential product recalls and other risks and uncertainties described in AMS' and Laserscope's Annual Reports on Form 10-K for the year ended December 31, 2005 and their other SEC filings.
Under the terms of the agreement, AMS will commence a tender offer to acquire all of the outstanding shares of Laserscope at a price of $31.
Emerson, President and CEO of American Medical Systems, commented, "The acquisition of Laserscope represents a truly strategic investment for AMS.
We believe the acquisition of Laserscope by AMS will further expand AMS' reputation as a leading urological products company.